In addition, the IDO-Kyn-AhR pathway has been evidenced to drive dormancy in tumor repopulating cells (TRCs), a highly tumorigenic subpopulation of cancer cells involved in the initiation and progression of tumorigenesis. The gene discussed is IDO1; the disease is cancer.